AIP
TLSA icon

ARS Investment Partners’s Tiziana Life Sciences TLSA Stock Holding History

ARS Investment Partners’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30,700
Closed -$66.3K – 213
2025
Q3 		$66.3K Buy
+30,700
New +$56.8K ﹤0.01% 202

Other funds holding TLSA

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ARS Investment Partners's TLSA Position: Q4 2025 in Review

ARS Investment Partners sold out of Tiziana Life Sciences (TLSA) in Q4 2025, closing a stake of 30,700 shares — an estimated $66.3K sold.

ARS Investment Partners first reported a position in TLSA in Q3 2025 and held it in 1 quarter. The position peaked at $66.3K in Q3 2025. 33 funds tracked by Wall St. Rank hold TLSA as of Q4 2025.

  • ARS Investment Partners reported no remaining Tiziana Life Sciences position as of Q4 2025 after selling out during the quarter.
  • ARS Investment Partners sold 30,700 Tiziana Life Sciences shares in Q4 2025, an estimated $66.3K.
  • ARS Investment Partners first reported a position in Tiziana Life Sciences in Q3 2025 and held it in 1 quarter.
  • ARS Investment Partners's Tiziana Life Sciences position peaked at $66.3K in Q3 2025.
  • 33 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q4 2025.

Based on ARS Investment Partners's 13F filing for Q4 2025, filed 5 Feb 2026.